Novasep invests $3.6M to boost HPAPI manufacturing capabilities

Monday, July 23, 2012

Novasep, a global supplier of manufacturing solutions to the life sciences industries, has invested $3.6 million to expand its Highly Potent API (HPAPI) manufacturing capabilities at its facility in Le Mans, France. The expansion has been designed to allow Novasep to serve the increased demand for manufacturing of novel anti-cancer therapies.

[Read More]